Clinical Trials · NCT01165944

Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus

WithdrawnPhase 1/Phase 2Pramlintide (Prohibited)
Phase
Phase 1/Phase 2
Recruitment status
Withdrawn
Sponsor
University of Colorado, Denver
Enrollment
0
Start date
Aug 2009
Locations
1 site, United States
Primary endpoint
HgA1c
View Pramlintide compound reference